Seven Mile Advisory’s AbbVie ABBV Stock Holding History

Seven Mile Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$502K	Sell	2,308 -1,158	-33%	-$257K	0.36%	56
2025 Q4	$792K	Sell	3,466 -2,179	-39%	-$496K	0.14%	81
2025 Q3	$1.31M	Buy	5,645 +2,363	+72%	+$481K	0.21%	69
2025 Q2	$609K	Buy	3,282 +266	+9%	+$49.4K	0.37%	47
2025 Q1	$632K	Buy	3,016 +239	+9%	+$46.5K	0.42%	41
2024 Q4	$493K	Buy	2,777 +102	+4%	+$18.8K	0.31%	59
2024 Q3	$528K	Buy	2,675 +522	+24%	+$97.4K	0.35%	55
2024 Q2	$369K	Buy	2,153 +41	+2%	+$6.79K	0.27%	75
2024 Q1	$385K	Buy	2,112 +115	+6%	+$19.8K	0.29%	72
2023 Q4	$309K	Sell	1,997 -79	-4%	-$11.5K	0.27%	84
2023 Q3	$309K	Buy	2,076 +354	+21%	+$52K	0.33%	74
2023 Q2	$232K	Buy	+1,722	New	+$253K	0.27%	91

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seven Mile Advisory's ABBV Position: Q1 2026 in Review

Seven Mile Advisory reduced its AbbVie (ABBV) stake by 33% in Q1 2026, selling an estimated $257K and leaving 2,308 shares worth $502K. The position accounts for 0.36% of the portfolio, ranked #56.

Seven Mile Advisory first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.31M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Seven Mile Advisory held 2,308 shares of AbbVie worth $502K as of Q1 2026.
Seven Mile Advisory sold 1,158 AbbVie shares in Q1 2026, an estimated $257K.
AbbVie made up 0.36% of Seven Mile Advisory's portfolio in Q1 2026, its #56 holding.
Seven Mile Advisory first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
Seven Mile Advisory's AbbVie position peaked at $1.31M in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Seven Mile Advisory's 13F filing for Q1 2026, filed 14 Apr 2026.